Gallbladder dysfunction caused by MYPT1 ablation triggers cholestasis-induced hepatic fibrosis in mice
Open Access
- 27 June 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 8 (7)
Abstract
Background: The incidence of gallbladder diseases is as high as 20%, but whether gallbladder diseases contribute to hepatic disorders remains unknown. Methods: Here, we established an animal model of gallbladder dysfunction and assessed the role of a diseased gallbladder in cholestasis-induced hepatic fibrosis (CIHF). Results: Mice with smooth muscle-specific deletion of Mypt1, the gene encoding the main regulatory subunit of myosin light chain phosphatase (myosin phosphatase target subunit 1 [MYPT1]), had apparent dysfunction of gallbladder motility. This dysfunction was evidenced by abnormal contractile responses, namely, inhibited cholecystokinin 8-mediated contraction and nitric oxide–resistant relaxation. As a consequence, the gallbladder displayed impaired bile filling and biliary tract dilation comparable to the alterations in CIHF. Interestingly, the mutant animals also displayed CIHF features, including necrotic loci by the age of 1 month and subsequently exhibited progressive fibrosis and hyperplastic/dilated bile ducts. This pathological progression was similar to the phenotypes of the animal model with bile duct ligation and patients with CIHF. The characteristic biomarker of CIHF, serum alkaline phosphatase activity, was also elevated in the mice. Moreover, we observed that the myosin phosphatase target subunit 1 protein level was able to be regulated by several reagents, including lipopolysaccharide, exemplifying the risk factors for gallbladder dysfunction and hence CIHF. Conclusions: We propose that gallbladder dysfunction caused by myosin phosphatase target subunit 1 ablation is sufficient to induce CIHF in mice, resulting in impairment of the bile transport system.Keywords
This publication has 39 references indexed in Scilit:
- MYPT1 Down-regulation by Lipopolysaccharide-SIAH1/2 E3 Ligase-Ubiquitin-Proteasomal Degradation Contributes to Colonic Obstruction of Hirschsprung DiseaseCellular and Molecular Gastroenterology and Hepatology, 2020
- Animal models of cholestasis: An update on inflammatory cholangiopathiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2019
- CPI-17-mediated contraction of vascular smooth muscle is essential for the development of hypertension in obese miceJournal of Genetics and Genomics, 2019
- Pathogenesis of biliary fibrosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018
- Gallbladder Dysfunction: Cholecystitis, Choledocholithiasis, Cholangitis, and Biliary DyskinesiaPrimary Care: Clinics in Office Practice, 2017
- Functions of the Gallbladder2016
- Orai1 forms a signal complex with SK3 channel in gallbladder smooth muscleBiochemical and Biophysical Research Communications, 2015
- Cancer risk in patients with cholelithiasis and after cholecystectomy: a nationwide cohort studyJournal of Gastroenterology, 2013
- Partial bile duct ligation in mice: A novel model of acute cholestasisSurgery, 2011
- Effect of Experimental Acalculous Cholecystitis on Gallbladder Smooth Muscle ContractilityDigestive Diseases and Sciences, 1999